Daiichi Sankyo, Inc.
- Membership Level
- Company Headquarters
- 211 Mt. Airy Road, Basking Ridge, NJ 07920
- Contact Name
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.
With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. For more information, please visit: www.daiichisankyo.com. For more information, please visit: www.daiichisankyo.com.
Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit www.dsi.com.
ENHERTU4U offers a suite of support programs to help patient prescribed
ENHERTU® (fam-trastuzumab deruxtecan-nxki) afford and access their medication.
Click here for more information, including Important Safety Information for ENHERTU.
Please see full Prescribing Information, including Boxed WARNING for Interstitial Lung Disease and Embryo-Fetal Toxicity, and Medication Guide at www.ENHERTUPI.com.
ENHERTU® is a registered trademark of Daiichi Sankyo Company, Limited.
© 2020 Daiichi Sankyo, Inc. and AstraZeneca. PP-US-EN-0714 07/20